Figure 4.
Effectiveness of “DCB + BMS strategy” versus “DES alone” or “BMS alone” for treating de novo lesions. Secondary clinical endpoints: (A) target lesion revascularization, (B) MI, and (C) death.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.